Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wittlin

Showing results (191-200 of 318) with videos related to

Pageof 32
Sort By:
Journal of Medicinal Chemistry|March 5, 2021
3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparumTanja C Knaab, Jana Held, Bjoern B Burckhardt, et al.
The Journal of Infectious Diseases|June 27, 2012
Identification of a new chemical class of antimalarialsRalf Brunner, Hamed Aissaoui, Christoph Boss, et al.
ACS Infectious Diseases|August 28, 2023
A Pyridyl-Furan Series Developed from the Open Global Health Library Block Red Blood Cell Invasion and Protein Trafficking in <i>Plasmodium falciparum</i> through Potential Inhibition of the Parasite's PI4KIIIB EnzymeDawson B Ling, William Nguyen, Oliver Looker, et al.
Journal of Cardiovascular Electrophysiology|July 15, 2023
Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devicesArwa Younis, Tania Arous, Robert Klempfner, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of ActionMokhitli Morake, Dale Taylor, Dina Coertzen, et al.
Chemmedchem|May 19, 2010
Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparumJulie G Geist, Susan Lauw, Victoria Illarionova, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
Chemmedchem|June 22, 2011
Antimalarial mannoxanes: hybrid antimalarial drugs with outstanding oral activity profiles and a potential dual mechanism of actionJames Chadwick, Richard K Amewu, Francesc Marti, et al.
Molecular Endocrinology (Baltimore, Md.)|February 14, 2006
Socs2 and elf5 mediate prolactin-induced mammary gland developmentJessica Harris, Prudence M Stanford, Kate Sutherland, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Pageof 32

Showing results (191-200 of 318) with videos related to

Sort By:
Pageof 32
Journal of Medicinal Chemistry|March 5, 2021
3-Hydroxy-propanamidines, a New Class of Orally Active Antimalarials Targeting Plasmodium falciparumTanja C Knaab, Jana Held, Bjoern B Burckhardt, et al.
The Journal of Infectious Diseases|June 27, 2012
Identification of a new chemical class of antimalarialsRalf Brunner, Hamed Aissaoui, Christoph Boss, et al.
ACS Infectious Diseases|August 28, 2023
A Pyridyl-Furan Series Developed from the Open Global Health Library Block Red Blood Cell Invasion and Protein Trafficking in <i>Plasmodium falciparum</i> through Potential Inhibition of the Parasite's PI4KIIIB EnzymeDawson B Ling, William Nguyen, Oliver Looker, et al.
Journal of Cardiovascular Electrophysiology|July 15, 2023
Effect of sodium glucose cotransporter 2 inhibitors on atrial tachy-arrhythmia burden in patients with cardiac implantable electronic devicesArwa Younis, Tania Arous, Robert Klempfner, et al.
ACS Medicinal Chemistry Letters|January 14, 2026
A Novel Class of Orally Bioavailable Phenylglycine-Benzoxaborole Conjugates with Antimalarial Activity and Potentially Novel Mechanism of ActionMokhitli Morake, Dale Taylor, Dina Coertzen, et al.
Chemmedchem|May 19, 2010
Thiazolopyrimidine inhibitors of 2-methylerythritol 2,4-cyclodiphosphate synthase (IspF) from Mycobacterium tuberculosis and Plasmodium falciparumJulie G Geist, Susan Lauw, Victoria Illarionova, et al.
American Journal of Clinical Oncology|October 22, 1998
Sequential treatment including high-dose chemotherapy with peripheral blood stem cell support in patients with high-risk stage II-III breast cancer: outpatient administration in community cancer centersL S Schwartzberg, R Birch, W H West, et al.
Chemmedchem|June 22, 2011
Antimalarial mannoxanes: hybrid antimalarial drugs with outstanding oral activity profiles and a potential dual mechanism of actionJames Chadwick, Richard K Amewu, Francesc Marti, et al.
Molecular Endocrinology (Baltimore, Md.)|February 14, 2006
Socs2 and elf5 mediate prolactin-induced mammary gland developmentJessica Harris, Prudence M Stanford, Kate Sutherland, et al.
Journal of Medicinal Chemistry|September 27, 2018
Antimalarial Lead-Optimization Studies on a 2,6-Imidazopyridine Series within a Constrained Chemical Space To Circumvent Atypical Dose-Response Curves against Multidrug Resistant Parasite StrainsClaire Le Manach, Tanya Paquet, Kathryn Wicht, et al.
Pageof 32